Fate Prediction of nonhypervascular hepatic nodule (NHN)

In the following model, the fate of nonhypervascular hepatic nodule (NHN), which is detected during hepatobiliary phase of Gd-EOB-DTPA MRI, is estimated if the nodule will grow 2 mm or more and/or will draw arterial supply within following 500 days. Please enter data in the corresponding boxes.

How old is he/she?	(years old)
Does the nodule show lower attenuation in an arterial phase of EOB-MRI?	(No, 0; Yes, 1)
Which is the background liver disease of the patient?	(HBV, 0; HCV, 1; Others, 2)
des-gamma-carboxy prothrombin	(mAU/ml)
Is the nodule judged to include fat deposition by MRI?	(No, 0; Yes, 1)